ATE296094T1 - Stickstoffmonoxid bildende zusammensetzungen zur behandlung von nagelbettinfektionen - Google Patents

Stickstoffmonoxid bildende zusammensetzungen zur behandlung von nagelbettinfektionen

Info

Publication number
ATE296094T1
ATE296094T1 AT02747613T AT02747613T ATE296094T1 AT E296094 T1 ATE296094 T1 AT E296094T1 AT 02747613 T AT02747613 T AT 02747613T AT 02747613 T AT02747613 T AT 02747613T AT E296094 T1 ATE296094 T1 AT E296094T1
Authority
AT
Austria
Prior art keywords
treatment
infections
nailbed
nitrogen monoxide
forming compositions
Prior art date
Application number
AT02747613T
Other languages
English (en)
Inventor
Nigel Benjamin
Original Assignee
Univ Aberdeen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Aberdeen filed Critical Univ Aberdeen
Application granted granted Critical
Publication of ATE296094T1 publication Critical patent/ATE296094T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/04—Nitro compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q3/00—Manicure or pedicure preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Birds (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
AT02747613T 2001-08-03 2002-08-02 Stickstoffmonoxid bildende zusammensetzungen zur behandlung von nagelbettinfektionen ATE296094T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0119011.5A GB0119011D0 (en) 2001-08-03 2001-08-03 Treatment of nail infections
PCT/GB2002/003575 WO2003013489A1 (en) 2001-08-03 2002-08-02 Treatment of nail infections with no

Publications (1)

Publication Number Publication Date
ATE296094T1 true ATE296094T1 (de) 2005-06-15

Family

ID=9919789

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02747613T ATE296094T1 (de) 2001-08-03 2002-08-02 Stickstoffmonoxid bildende zusammensetzungen zur behandlung von nagelbettinfektionen

Country Status (23)

Country Link
US (2) US20050037093A1 (de)
EP (1) EP1411908B1 (de)
JP (1) JP2005501069A (de)
KR (1) KR20040031780A (de)
CN (1) CN1321633C (de)
AT (1) ATE296094T1 (de)
AU (1) AU2002318001B2 (de)
BR (1) BR0211390A (de)
CA (1) CA2453243C (de)
DE (1) DE60204322T2 (de)
ES (1) ES2242042T3 (de)
GB (1) GB0119011D0 (de)
HR (1) HRP20040059B1 (de)
HU (1) HUP0401190A3 (de)
IL (2) IL159724A0 (de)
MX (1) MXPA04000670A (de)
NO (1) NO20040258L (de)
NZ (1) NZ530577A (de)
PL (1) PL213555B1 (de)
PT (1) PT1411908E (de)
RU (1) RU2298403C2 (de)
WO (1) WO2003013489A1 (de)
ZA (1) ZA200400491B (de)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0125222D0 (en) * 2001-10-19 2001-12-12 Barts & London Nhs Trust Composition for the treatment of microbial infections
JP5564158B2 (ja) * 2003-07-09 2014-07-30 ザ ガバメント オブ ザ ユナイテッド ステイツ オブ アメリカ アズ リプレゼンテッド バイ ザ セクレタリー オブ ザ デパートメント オブ ヘルス アンド ヒューマン サービシーズ 亜硝酸塩によって特定の心臓血管状態を処置する方法
US7362274B1 (en) * 2004-07-09 2008-04-22 Huan-Cheng Lien Coupled feed-in butterfly shaped left/right hand circularly polarized microstrip antenna
EP1871433B1 (de) * 2005-03-24 2009-04-22 NOLabs AB Kosmetische behandlung mit stickoxid, vorrichtung zur durchführung dieser behandlung und herstellungsverfahren dafür
WO2006125123A2 (en) * 2005-05-19 2006-11-23 University Of Cincinnati Methods for treating bacterial respiratory tract infections in an individual using acidified nitrite
EP1888510A4 (de) 2005-05-27 2013-01-16 Univ North Carolina Stickoxidfreisetzende partikel für stickoxidtherapeutika und biomedizinische anwendungen
JP5165217B2 (ja) * 2006-07-07 2013-03-21 生化学工業株式会社 ゲル状又はフィルム状組成物並びにその製造方法及び用途
GB0618711D0 (en) * 2006-09-22 2006-11-01 Univ Exeter Agricultural treatment
WO2009055008A1 (en) * 2007-10-24 2009-04-30 Wharton Innovative Products, Llc Two part lotion for the delivery of nitrite ions to the skin
AU2008322437B2 (en) 2007-11-15 2013-11-07 Louisiana State University Use of nitrite salts in chronic ischemia
EP2237788A4 (de) * 2007-12-27 2013-06-05 Aires Pharmaceuticals Inc Aerosolisierte nitrit- und stickoxidspendende verbindungen und ihre verwendung
US8303995B1 (en) * 2008-06-13 2012-11-06 Board Of Regents, The University Of Texas System Nitrite formulations and their use as nitric oxide prodrugs
WO2010044875A2 (en) * 2008-10-16 2010-04-22 Novan, Inc. Nitric oxide releasing particles for oral care applications
CA2740135A1 (en) * 2008-10-30 2010-05-06 Chris Miller Wound dressings comprising a nitric oxide gas producing component and an oxygen releasing component
WO2011022652A1 (en) 2009-08-21 2011-02-24 Novan, Inc. Topical gels
BR112012003804B1 (pt) 2009-08-21 2019-02-19 Novan, Inc. Curativo para ferimentos, método para formar um curativo para ferimentos, e, kit de curativo para ferimento
WO2011047013A1 (en) * 2009-10-13 2011-04-21 Novan, Inc. Nitric oxide-releasing coatings
ES2633618T3 (es) * 2009-10-14 2017-09-22 Theravasc Inc. Formulaciones farmacéuticas de nitrito y sus usos
US20130089629A1 (en) * 2010-06-07 2013-04-11 Topical Pharma Ab Kit for the treatment of onychomycosis by nitric oxide
US8591876B2 (en) 2010-12-15 2013-11-26 Novan, Inc. Methods of decreasing sebum production in the skin
ES2695173T3 (es) 2011-02-28 2019-01-02 Novan Inc Partículas de sílice modificadas con S-nitrosotiol que liberan óxido nítrico y procedimientos de fabricación de las mismas
WO2012131412A2 (en) 2011-03-31 2012-10-04 Szabo Laszlo Gabor Pharmaceutical composition containing no, process for the preparation and use thereof
ES2804263T3 (es) 2011-07-05 2021-02-05 Novan Inc Composiciones tópicas
US9737362B2 (en) * 2011-07-06 2017-08-22 Boston Scientific Scimed, Inc. Tissue cutting systems and methods
MX388990B (es) 2011-08-17 2025-03-20 Univ Texas Método de producción de niveles fisiológicos y terapéuticos de óxido nítrico por medio de un sistema de suministro oral.
ES2861439T3 (es) 2012-03-14 2021-10-06 Novan Inc Composiciones farmacéuticas que liberan óxido nítrico
WO2014130691A2 (en) 2013-02-20 2014-08-28 Theravasc Inc. Pharmaceutical formulations of nitrite and uses thereof
US9855211B2 (en) 2013-02-28 2018-01-02 Novan, Inc. Topical compositions and methods of using the same
US12233289B2 (en) 2013-08-01 2025-02-25 Olaplex, Inc. Methods for fixing hair and skin
US9095518B2 (en) 2013-08-01 2015-08-04 Liqwd, Inc. Methods for fixing hair and skin
US11813284B2 (en) 2013-08-08 2023-11-14 Novan, Inc. Topical compositions and methods of using the same
AU2015229626B2 (en) 2014-03-14 2021-05-20 Sanotize Research And Development Corp. Treating diseases using nitric oxide releasing solutions
MX389718B (es) 2014-05-16 2025-03-20 Olaplex Inc Formulaciones y metodos de tratamiento con queratina.
US10322082B2 (en) 2014-07-11 2019-06-18 Novan, Inc. Topical antiviral compositions and methods of using the same
EP3166593B1 (de) 2014-07-11 2020-05-20 Novan, Inc. Topische antivirale zusammensetzungen und verfahren zur verwendung davon
US10925689B2 (en) 2014-07-14 2021-02-23 Novan, Inc. Nitric oxide releasing nail coating compositions, nitric oxide releasing nail coatings, and methods of using the same
EP3177262A4 (de) 2014-08-08 2018-04-18 Novan Inc. Topische emulsionen
US9597273B2 (en) 2015-04-24 2017-03-21 Liqwd, Inc. Methods for treating relaxed hair
WO2017019614A1 (en) 2015-07-28 2017-02-02 Novan, Inc. Combinations and methods for the treatment and/or prevention of fungal infections
US10912743B2 (en) 2016-03-02 2021-02-09 Novan, Inc. Compositions for treating inflammation and methods of treating the same
US11166980B2 (en) 2016-04-13 2021-11-09 Novan, Inc. Compositions, systems, kits, and methods for treating an infection
US9872821B1 (en) 2016-07-12 2018-01-23 Liqwd, Inc. Methods and formulations for curling hair
WO2018236803A1 (en) 2017-06-19 2018-12-27 Novan, Inc. Topical compositions and methods of using the same
WO2019169221A1 (en) 2018-03-01 2019-09-06 Novan, Inc. Nitric oxide releasing suppositories and methods of use thereof
US11472705B2 (en) 2018-03-13 2022-10-18 Sanotize Research And Development Corp. Nitric oxide releasing compositions
RU2704782C1 (ru) * 2018-10-09 2019-10-30 Елена Владимировна Герасимчук Способ криогенного лечения онихомикоза
GB2599818B (en) 2019-06-04 2024-01-31 Thirty Respiratory Ltd Methods and compositions for generating nitric oxide and uses thereof to deliver nitric oxide via the respiratory tract
EP3980373A1 (de) * 2019-06-04 2022-04-13 Thirty Holdings Limited Verfahren und zusammensetzungen zur erzeugung von stickstoffmonoxid und verwendungen davon
BR112022021454A2 (pt) 2020-04-23 2023-01-31 Thirty Respiratory Ltd Óxido nítrico ou composições liberadoras de óxido nítrico para uso no tratamento de sars-cov e sars-cov-2
JP2023526583A (ja) 2020-04-23 2023-06-22 サーティー レスピラトリー リミテッド 結核を治療及び抑制するための方法及び組成物
BR112023000788A2 (pt) * 2020-07-16 2023-05-09 Sanotize Res And Development Corp Métodos de tratamento de condições que respondem à terapia com óxido nítrico
RU2769437C1 (ru) * 2021-07-08 2022-03-31 Светлана Николаевна Абрамова Способ восстановления роста ногтя
GB2644374A (en) * 2024-09-20 2026-04-08 Thirty Holdings Ltd Compositions and kits for generating nitric oxide

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY128187A (en) * 1993-06-23 2007-01-31 Icn Switzerland Ag Preparation for skin and mucous membrane
US6709681B2 (en) * 1995-02-17 2004-03-23 Aberdeen University Acidified nitrite as an antimicrobial agent
DK0746327T3 (da) 1994-02-21 2004-05-10 Univ Aberdeen Forsuret nitrit som antimikrobielt middel
GB9804469D0 (en) * 1998-03-02 1998-04-29 Univ Aberdeen Antiviral composition
US6103275A (en) * 1998-06-10 2000-08-15 Nitric Oxide Solutions Systems and methods for topical treatment with nitric oxide

Also Published As

Publication number Publication date
RU2298403C2 (ru) 2007-05-10
CA2453243C (en) 2012-01-03
JP2005501069A (ja) 2005-01-13
US9381381B2 (en) 2016-07-05
CN1564681A (zh) 2005-01-12
US20050037093A1 (en) 2005-02-17
MXPA04000670A (es) 2004-10-27
CA2453243A1 (en) 2003-02-20
CN1321633C (zh) 2007-06-20
KR20040031780A (ko) 2004-04-13
DE60204322T2 (de) 2006-01-26
AU2002318001B2 (en) 2007-02-15
GB0119011D0 (en) 2001-09-26
PL213555B1 (pl) 2013-03-29
PL366579A1 (en) 2005-02-07
EP1411908A1 (de) 2004-04-28
PT1411908E (pt) 2005-08-31
IL159724A0 (en) 2004-06-20
EP1411908B1 (de) 2005-05-25
HRP20040059A2 (en) 2004-08-31
HUP0401190A2 (hu) 2004-11-29
RU2004101765A (ru) 2005-03-10
HRP20040059B1 (hr) 2008-05-31
IL159724A (en) 2006-04-10
ZA200400491B (en) 2005-04-22
NZ530577A (en) 2007-01-26
US20100015253A1 (en) 2010-01-21
HUP0401190A3 (en) 2008-08-28
DE60204322D1 (de) 2005-06-30
NO20040258L (no) 2004-03-29
ES2242042T3 (es) 2005-11-01
WO2003013489A1 (en) 2003-02-20
BR0211390A (pt) 2004-08-17

Similar Documents

Publication Publication Date Title
ATE296094T1 (de) Stickstoffmonoxid bildende zusammensetzungen zur behandlung von nagelbettinfektionen
DE602004024572D1 (de) Zusammensetzungen, die sich als inhibitoren von proteinkinasen eignen
TNSN05254A1 (en) Derivatives of 2-acylamino-4-phenylthiazole, preparation method thereof and application of same in therapeutics
EA200500169A1 (ru) Замещенные производные 1,3-дифенилпроп-2-ен-1-она, получение и применение
AU2002319814A1 (en) Substituted 1h-dihydropyrazoles, their preparation and use
TW200510416A (en) P38 inhibitors and methods of use thereof
ATE495739T1 (de) Pharmazeutische zusammensetzungen und verfahren zur verwendung von levodopa und carbidopa
DE602004017871D1 (de) Zubereitungen zur behandlung von arthritischen erscheinungen
NO20050091L (no) Fremgangsmater for fremstilling av fibrinogen
UA88645C2 (ru) Гетероарильные соединения как бета-миметики для лечения заболеваний дыхательных путей
NO20055741L (no) Nye kjemiske forbindelser
EP1423137A4 (de) Lipopeptid-stereoisomere, verfahren zu ihrer herstellung und nützliche zwischenprodukte
ATE323693T1 (de) Calciumkanalantagonisten vom n-typ zur behandlung von schmerzen
DE60316821D1 (de) Aminobenzothiazolverbindungen mit nos-hemmender wirkung
CY1113871T1 (el) Διαδικασια παρασκευης γκαμπαπεντινης
MXPA05009014A (es) Antagonistas del receptor ccr-3.
UA83821C2 (ru) Производные бензолсульфонамидов, способ их получения и их применение для лечения воспалительных заболеваний и утоления боли
ATE335739T1 (de) Cak inhibitoren und deren verwendungen
EA200600992A1 (ru) Амиды тиазолидинона, амиды тиазолидинкарбоновой кислоты, способы их получения и их применение
DE602004019541D1 (de) Cycloalkyläbü kondensierte indole
ATE363890T1 (de) Kationische polymerisate und deren verwendung in kosmetischen formulierungen
MXPA06007007A (es) Derivados de prolina usados como ingredientes farmaceuticos activos para el tratamiento de tumores.
CY1108980T1 (el) Χρηση πολυσουλφωμενων κυκλοδεξτρινων για τη θεραπεια της αρθριτιδας
ATE460168T1 (de) Nicht-radioaktives strontiummittel zur behandlung von krebs
EA200701852A1 (ru) Производные аминокислот

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1411908

Country of ref document: EP

REN Ceased due to non-payment of the annual fee